Location History:
- Valby, DK (2019 - 2024)
- Vaerloese, DK (2023 - 2024)
Company Filing History:
7 out of 1,371 
1 out of 17,167 
1 out of 2,056 
Years Active: 2019-2025
Title: The Innovative Journey of Iben Damager
Introduction: Iben Damager, an accomplished inventor based in Valby, Denmark, has made significant strides in the field of biotechnology with a particular focus on alpha-amylase variants. With a total of eight patents to his name, Damager's work exemplifies the intersection of scientific research and practical application, greatly benefiting industries such as food and cleaning.
Latest Patents: Iben Damager's latest inventions revolve around alpha-amylase variants. One of his notable patents describes variants of a parent alpha-amylase that exhibit improved wash performance compared to their parent counterparts. This invention not only includes the alpha-amylase variants themselves but also encompasses polynucleotides encoding these variants, nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides. Another key patent focuses on the alpha-amylase variants and related polynucleotides, further detailing methods of utilizing these innovative variations to achieve enhanced performance.
Career Highlights: Throughout his career, Damager has been associated with leading biotech companies, notably Novozymes A/S. His work at Novozymes A/S has allowed him to contribute to the development of enzyme technology that drives efficiency in various applications. His expertise in the field is well recognized, and he continues to push the boundaries of what is possible with enzyme innovation.
Collaborations: During his journey, Iben Damager has collaborated with accomplished peers such as Carsten Schau Andersen and Chakshusmathi Ghadiyaram, a talented woman whose contributions have further enriched his research endeavors. Together, these collaborations have fostered innovation and propelled advancements in the biotechnology sector.
Conclusion: Iben Damager stands out as a prominent inventor in the realm of enzyme technology, particularly in the development of alpha-amylase variants. His eight patents reflect a commitment to innovation and illustrate the importance of scientific research in enhancing everyday applications. As the field of biotechnology continues to evolve, Damager's contributions will undoubtedly pave the way for future advancements and inspire the next generation of inventors.